14 July 2026
Linklaters advises Bayer on Apollo´s €3bn equity capital investment in its long acting reversible contraceptives business
Advising firms
Deal team
16 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Carl Sanders Lead | Linklaters | Partner | Private Capital | Not stated |
| Dr Alexander Schlee Lead | Linklaters | Partner | Capital Markets | Not stated |
| Nikita Selivanov | Linklaters | Counsel | Private Capital | Not stated |
| Arne Kießling | Linklaters | Partner | Corporate/M&A | Not stated |
| Guido Portier | Linklaters | Partner | Corporate/M&A | Not stated |
| Marleen Wessel | Linklaters | Partner | Corporate/M&A | Amsterdam |
| Oliver Rosenberg | Linklaters | Partner | Tax | Not stated |
| Anna-Livia von Lüdinghausen | Linklaters | Counsel | Banking | Not stated |
| Isabelle-Carmen Petersen Weis | Linklaters | Counsel | Banking | Not stated |
| Philipp Meyer Reichen | Linklaters | Senior associate | Corporate/M&A | Not stated |
| Tobias Buddemeier | Linklaters | Senior associate | Corporate/M&A | Not stated |
| Sebastian Plötz | Linklaters | Associate | Private Capital | Not stated |
| Lena Mühleisen | Linklaters | Associate | Private Capital | Not stated |
| Ruth van der Haar | Linklaters | Associate | Corporate/M&A | Amsterdam |
| Carolien Lode | Linklaters | Associate | Corporate/M&A | Amsterdam |
| Pascal Janssen Jägers | Linklaters | Associate | Tax | Not stated |
13 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 3bn (€3bn)
- What the figure measures
- Total transaction value
- Client
- Bayer AGSell-side
- Counterparties
- Apollo (Buy-side)